Tweet from EricTopol at September 27, 2022 at 05:12PM
Has the β-amyloid hypothesis for Alzheimer’s (AD) finally been proven? Results of a Phase 3, placebo-controlled trial of a monoclonal Ab in 1,800 participants with early stage AD raises the possibility (need to see all the data)
https://t.co/npXgPzNAht https://t.co/OYlvevWCNv— Eric Topol (@EricTopol)
Sep 28, 2022
from http://twitter.com/EricTopol